ArticleMicromachines2026
A Laminar Microfluidic Platform for Probing the Effects of Spatially Heterogeneous Drug Distributions.
Article in Micromachines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
We herein designed a 64-chamber laminar-flow microfluidic chip with independently addressable culture units capable of establishing spatially heterogeneous chemical environments to mimic tissue microenvironments. Stable chemical gradients were successfully generated within the chip through controlled laminar flow, allowing precise spatial modulation of cellular exposure. Using TNF-α as a model stimulus, we observed a clear time delay in NF-κB activation between cells directly exposed to the cytokine and those located on the medium-only side, confirming the establishment of spatially distinct chemical conditions. Notably, even cells not directly exposed to TNF-α eventually responded, indicating that molecular diffusion along the static solid-liquid interface serves as an effective delivery route for bioactive molecules. To further demonstrate the platform's utility, we constructed a skin-mimetic co-culture model of HaCaT keratinocytes and human skin fibroblasts (HSFs) to assess the diffusion and cytotoxic effects of 5-fluorouracil (5-FU). The results revealed that fibroblasts provided protective effects against 5-FU-induced cytotoxicity, likely via paracrine signaling or direct cell-cell interactions. These findings highlight the platform's capacity for probing not only spatial drug-delivery dynamics but also intercellular interactions under physiologically relevant conditions. This system offers a powerful and versatile tool for studying spatiotemporal signaling, drug screening, and topical therapeutic development.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.